You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 5,330,841


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,330,841
Title: Aqueous coating composition and its use for coating mineral substrates
Abstract:The present invention relates to a coating composition which contains A) 100 parts by weight of a water-soluble polyether component having an average hydroxyl functionality of least 2.5 and an average OH number of 100 to 600 and containing at least one polyether polyol, B) 40 to 240 parts by weight of a water-soluble or water-dispersible polyisocyanate component containing at least one nonionically/hydrophilically modified organic polyisocyanate having (cyclo)aliphatically bound isocyanate groups, C) 10 to 50 parts by weight magnesium oxide and/or hydroxide in finely dispersed form and D) 50 to 150 parts by weight water. The present invention also relates to mineral substrates coated with this coating composition.
Inventor(s): Gruber; Hermann (Leverkusen, DE), Reiff; Helmut (Leverkusen, DE), Kober; Hermann (Bergisch Gladbach, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:07/891,535
Patent Claims:1. An aqueous coating composition comprising

A) 100 parts by weight of a water-soluble polyether component having an average hydroxyl functionality of least 2.5 and an average OH number of 100 to 600 and containing at least one polyether polyol,

B) 40 to 240 parts by weight of a water-soluble or water-dispersible polyisocyanate component containing at least one nonionically/hydrophilically modified organic polyisocyanate having (cyclo)aliphatically bound isocyanate groups,

C) 10 to 50 parts by weight of magnesium oxide and/or hydroxide in finely dispersed form and

D) 50 to 150 parts by weight water.

2. A mineral substrate which is coated with the coating composition of claim 1.

3. The aqueous coating composition of claim 1 wherein component B) comprises a member selected from the group consisting of the reaction product of i) a monohydric or polyhydric polyalkylene ether alcohol containing at least one polyether chain bearing at least 10 ethylene oxide units with ii) an isocyanurate-modified polyisocyanate prepared from a monomeric diisocyanate, a uretdione-modified polyisocyanate prepared from a monomeric diisocyanate; a urethane and/or alphanate-modified polyisocyanate prepared from a monomeric diisocyanate, a biuret-modified polyisocyanate prepared from 1,6-diisocyanatohexane and bis-(6-isocyanatohexyl)-oxadiazine trione.

4. The aqueous coating composition of claim 3 wherein said polyalkylene ether alcohol is monohydric.

5. The aqueous coating composition of claim 1 wherein component C) is present in an amount of 20 to 30 parts by weight.

6. The aqueous coating composition of claim 3 wherein component C) is present in an amount of 20 to 30 parts by weight.

7. The aqueous coating composition of claim 4 wherein component C) is present in an amount of 20 to 30 parts by weight.

8. An aqueous coating composition comprising

A) 100 parts by weight of a water-soluble polyether component having an average hydroxyl functionality of at least 2.5 and an average OH number of 100 to 600 and containing at least one polyether polyol,

B) 100 to 200 parts by weight of a water-soluble or water-dispersible polyisocyanate component containing at least one nonionically/hydrophically modified organic polyisocyanate having (cyclo)aliphatically bound isocyanate groups,

C) 10 to 50 parts by weight of magnesium oxide and/or hydroxide in finely dispersed form and

D) 50 to 150 parts by weight water.

9. The aqueous coating composition of claim 8 wherein component B) comprises a member selected from the group consisting of the reaction product of i) a monohydric or polyhydric polyalkylene ether alcohol containing at least one polyether chain bearing at least 10 ethylene oxide units with ii) an isocyanurate-modified polyisocyanate prepared from a monomeric diisocyanate; a uretdione-modified polyisocyanate prepared from a monomeric diisocyanate, a urethane and/or allophanate-modified polyisocyanate prepared from a monomeric diisocyanate, a biuret-modified polyisocyanate prepared from 1,6-diisocyanatohexane and bis-(6-isocyanatohexyl)-oxadiazine trione.

10. The aqueous coating composition of claim 9 wherein said polyalkylene ether alcohol is monohydric.

11. The aqueous coating composition of claim 8 wherein component C) is present in an amount of 20 to 30 parts by weight.

12. The aqueous coating composition of claim 9 wherein component C) is present in an amount of 20 to 30 parts by weight.

13. The aqueous coating composition of claim 10 wherein component C) is present in an amount of 20 to 30 parts by weight.

Details for Patent 5,330,841

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Biologicals Llc ALPHANATE antihemophilic factor/von willebrand factor complex (human) For Injection 102475 08/15/1978 ⤷  Try a Trial 2011-07-19
Grifols Biologicals Llc ALPHANATE antihemophilic factor/von willebrand factor complex (human) For Injection 102475 06/26/2014 ⤷  Try a Trial 2011-07-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.